1 line
8.2 KiB
JSON
1 line
8.2 KiB
JSON
{"Addison's disease": 10.721286382533403, "Adrenal disorder": 24.177262636318197, "Adrenal insufficiency": 89.26868147766206, "Adrenocortical insufficiency acute": 27.73348853346601, "Adrenocorticotropic hormone deficiency": 314.68175790908253, "Alanine aminotransferase increased": 2.1454070062029933, "Amylase increased": 4.95806308725641, "Aspartate aminotransferase increased": 2.3023644968115566, "Autoimmune colitis": 95.6025489184596, "Autoimmune dermatitis": 78.15567788188058, "Autoimmune haemolytic anaemia": 4.155068233475303, "Autoimmune hepatitis": 26.58098832801254, "Autoimmune nephritis": 37.69317824285383, "Autoimmune pancreatitis": 41.17946796875452, "Autoimmune thyroiditis": 10.513798600314455, "Blood corticotrophin decreased": 62.27091645409207, "Blood creatine phosphokinase increased": 2.1419227580911206, "Blood thyroid stimulating hormone abnormal": 19.05353379167592, "Blood thyroid stimulating hormone decreased": 10.746159253462151, "Blood thyroid stimulating hormone increased": 2.940238192872663, "Brain oedema": 2.2233192991500506, "Bronchopulmonary aspergillosis": 2.852820722390136, "C-reactive protein increased": 2.6225406050329614, "Central hypothyroidism": 26.05312368843499, "Cholangitis": 9.07120859395352, "Cholangitis sclerosing": 18.55649613057516, "Cholecystitis": 2.9151497116995624, "Cholestasis": 2.398980272128844, "Chronic gastritis": 3.407306997076868, "Colitis": 37.01876210175181, "Colitis microscopic": 5.047996020770578, "Coronavirus infection": 3.072776966096285, "Cortisol decreased": 17.502826210074264, "Cytokine release syndrome": 11.937667423042948, "Cytomegalovirus enterocolitis": 13.245436749455424, "Decreased appetite": 2.909912975254876, "Dermatitis": 4.014861616193892, "Dermatitis psoriasiform": 6.18950933479755, "Diabetic ketoacidosis": 3.257024816621925, "Diarrhoea": 2.0473042002501045, "Disseminated intravascular coagulation": 6.33840348610658, "Drug eruption": 5.390890298927222, "Drug-induced liver injury": 4.198708814983744, "Duodenal ulcer": 2.243668147278874, "Duodenitis": 8.178438769507647, "Dyslalia": 5.147577799946268, "Encephalitis": 10.964496760472093, "Encephalitis autoimmune": 13.15738855375916, "Endocrine disorder": 19.05909630543023, "Enteritis": 6.857863249905643, "Enterocolitis": 30.508664701013632, "Eosinophil count increased": 4.270700288981342, "Erythema multiforme": 7.386131501351977, "Eyelid ptosis": 5.760881421450782, "Febrile neutropenia": 2.621422649534555, "Fulminant type 1 diabetes mellitus": 176.56552251434485, "Gastritis": 2.026011428351472, "Gastrointestinal perforation": 4.875137917493226, "Glucocorticoid deficiency": 27.08891849697116, "Graves' disease": 3.2690845328398903, "Guillain-Barre syndrome": 3.6578166407226256, "Haemophagocytic lymphohistiocytosis": 16.57668238767877, "Hair colour changes": 2.031473398392185, "Hepatic cytolysis": 4.644697985158562, "Hepatic failure": 2.0937343647489457, "Hepatic function abnormal": 8.778091511202947, "Hepatitis": 9.805443579049854, "Hepatitis acute": 2.721252679289698, "Hepatitis fulminant": 4.283665611637545, "Hepatotoxicity": 3.769746093408006, "Hypercalcaemia": 2.2228626430324225, "Hyperlipasaemia": 10.321826929736323, "Hyperthyroidism": 16.87828333167245, "Hypertransaminasaemia": 2.152801648897868, "Hypophysitis": 166.2949415065339, "Hypopituitarism": 224.7886056633029, "Hypothalamo-pituitary disorder": 61.05255206910652, "Hypothyroidism": 19.828938271863997, "Immune thrombocytopenia": 3.2852145534871084, "Immune-mediated adrenal insufficiency": 233.0824053732555, "Immune-mediated adverse reaction": 111.99013875702488, "Immune-mediated arthritis": 91.7969739074402, "Immune-mediated cholangitis": 70.12170709435715, "Immune-mediated dermatitis": 385.580392753696, "Immune-mediated encephalitis": 68.50200807486466, "Immune-mediated endocrinopathy": 135.6052457121074, "Immune-mediated enterocolitis": 153.57751843105626, "Immune-mediated gastritis": 80.50611893721674, "Immune-mediated hepatic disorder": 206.16830038711043, "Immune-mediated hepatitis": 99.53363435730144, "Immune-mediated hyperthyroidism": 59.723152833924566, "Immune-mediated hypophysitis": 136.43005773823856, "Immune-mediated hypothyroidism": 55.93186619878118, "Immune-mediated lung disease": 152.35088760516322, "Immune-mediated myasthenia gravis": 37.014866421035, "Immune-mediated myocarditis": 71.98375210372812, "Immune-mediated myositis": 53.16995419712262, "Immune-mediated nephritis": 108.7827885815122, "Immune-mediated neuropathy": 37.32379813315822, "Immune-mediated pancreatitis": 105.10613000328917, "Immune-mediated renal disorder": 98.88086835554972, "Immune-mediated thyroiditis": 85.8837163156792, "Immune-mediated uveitis": 54.84933703834195, "Infectious pleural effusion": 7.630901397794385, "Infusion related reaction": 2.671359213541632, "Intentional product use issue": 16.126217029358234, "Interstitial lung disease": 15.237270037331374, "Intestinal perforation": 3.459910889222848, "Large intestine perforation": 3.873264263300012, "Leukoderma": 230.95446120214768, "Lichenoid keratosis": 6.208279406740189, "Lipase increased": 3.2232245572285403, "Liver disorder": 11.26697223504703, "Lung opacity": 4.340232951173019, "Lymphangiosis carcinomatosa": 11.343486180993914, "Lymphocytic hypophysitis": 110.31049889217404, "Malignant neoplasm progression": 25.993291592963157, "Malignant pleural effusion": 7.970671401605895, "Meningitis": 4.957867972420475, "Meningitis aseptic": 9.269458446645515, "Metastases to bone": 3.940960003961727, "Metastases to central nervous system": 13.022718873683932, "Metastases to liver": 3.0259874143756504, "Metastases to lung": 3.818139964867101, "Metastases to lymph nodes": 4.581561098716215, "Metastases to meninges": 5.882507387465225, "Metastases to spine": 6.397980894324145, "Metastatic malignant melanoma": 3.885011201384616, "Myasthenia gravis": 22.258222480237016, "Myasthenic syndrome": 9.244769872030815, "Myocarditis": 6.062662293770092, "Myositis": 25.150991347116992, "Nephritis": 13.70680988880464, "Neuropathy peripheral": 2.718925553407311, "Neutrophil count decreased": 3.676145429187547, "Non-small cell lung cancer": 430.24269236953, "Oesophagitis": 2.219618530629032, "Organising pneumonia": 12.062849410281848, "Pancreatic enzymes increased": 7.751427497641741, "Pemphigoid": 4.0324965854222174, "Performance status decreased": 3.0128219635834146, "Peripheral sensory neuropathy": 4.0890285886855136, "Peritonitis": 2.603082735384791, "Physical deconditioning": 3.407527251903232, "Pituitary enlargement": 66.88881843522914, "Platelet count decreased": 2.11562675035154, "Pleural effusion": 2.897935649652122, "Pneumocystis jirovecii pneumonia": 3.897909439326853, "Pneumonia aspiration": 3.1114679618671586, "Pneumonia bacterial": 7.333087599237727, "Pneumonitis": 22.54156935062784, "Polyarthritis": 3.054261960266129, "Polymyalgia rheumatica": 7.063942355122454, "Polymyositis": 9.135383838466224, "Prescribed overdose": 4.195065923211207, "Prescribed underdose": 4.590715224437839, "Primary adrenal insufficiency": 35.38583373398441, "Primary hypothyroidism": 32.870005717940174, "Pulmonary toxicity": 15.986156831300322, "Radiation pneumonitis": 32.73041213859531, "Rash": 2.5183700269706653, "Rash maculo-papular": 2.797687070726397, "Renal disorder": 2.8576307290107894, "Renal impairment": 2.1334675891689945, "Sarcoidosis": 3.400919556746724, "Secondary adrenocortical insufficiency": 214.4315939123931, "Sialoadenitis": 10.437767186324118, "Silent thyroiditis": 185.3268309983824, "Sjogren's syndrome": 3.701618463095721, "Skin disorder": 7.958009716743746, "Skin toxicity": 5.198866120923339, "Steroid diabetes": 7.85353687757981, "Stevens-Johnson syndrome": 2.238393996782843, "Thrombophlebitis migrans": 42.0414189899959, "Thyroid disorder": 13.751972503811968, "Thyroiditis": 65.88600664414933, "Thyroiditis subacute": 7.0407337600354944, "Thyrotoxic crisis": 12.941417456050493, "Toxic epidermal necrolysis": 2.503009088371614, "Troponin increased": 2.364477633319907, "Tubulointerstitial nephritis": 9.04539935680851, "Tumour haemorrhage": 7.962916417110066, "Tumour lysis syndrome": 4.7530033151256585, "Tumour pseudoprogression": 62.74309221286461, "Type 1 diabetes mellitus": 21.305147466049306, "Uveitis": 7.802749831210593, "Vitiligo": 11.99276302293395, "Vogt-Koyanagi-Harada disease": 39.36864820526257} |